Q4 2022 Holdings
Filed 2023-01-25 | 60 holdings | $4.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| XP Inc(XP) | Common Stock | G98239109 | $31.5K | 2,051,906 | 0.7% |
| Acadia Pharmaceuticals Inc(ACAD) | Common Stock | 004225108 | $266.0K | 16,739 | 6.0% |
| Ascendis Pharma(ASND) | ADR | 04351P101 | $278.0K | 2,276 | 6.3% |
| Biomarin Pharmaceutical Inc(BMRN) | Common Stock | 09061G101 | $281.0K | 2,713 | 6.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | Common Stock | 02043Q107 | $412.0K | 1,733 | 9.3% |
| Centene Corp(CNC) | Common Stock | 15135B101 | $425.0K | 5,185 | 9.6% |
| Abbvie Inc(ABBV) | Common Stock | 00287Y109 | $429.0K | 2,656 | 9.7% |
| Argenx SE(ARGX) | ADR | 04016X101 | $566.0K | 1,495 | 12.8% |
| Amazon.com Inc(AMZN) | Common Stock | 023135106 | $714.0K | 8,500 | 16.1% |
| Beigene LTD(ONC) | ADR | 07725L102 | $917.0K | 4,169 | 20.7% |